CJC 1295 (without DAC) CND2 2mg*10vials

CJC 1295 DAC-free CND2 2mg x 10 Vials

Product Overview

CJC 1295 DAC-free CND2 is a high-purity short-acting physiological growth hormone-releasing hormone analog research peptide, serving as the basic version of the CND series of pulse-type products. Unlike DAC-modified long-acting variants, this non-DAC structure supports albumin-binding modification avoidance research, exhibiting natural metabolic clearance and precise short half-life pulse-release characteristic research. Its precise 2mg dosage is optimized for physiological pulse GH and IGF-1 axis studies, short-cycle dose-response model construction, acute endocrine intervention validation, and safe baseline metabolic mechanism studies. It supports pure natural growth hormone secretion rhythm research without long-term accumulation related studies, serving as a core baseline research material for exploring physiological endocrine regulation and acute metabolic composition of growth hormone peptides.

Core Research Functions

Physiological Pulse of Endogenous GHRH Mimicry: Supports endogenous GHRH physiological pulse accurate mimicry research, acute orderly growth hormone secretion triggering studies, and transient moderate IGF-1 increase research.

DAC Absence and Natural Rapid Metabolic Clearance: Supports DAC absence research, albumin non-retention studies, excess peptides natural rapid metabolization research, and long-term accumulation and continuous hormonal additive effects in the body related avoidance research.

Physiological Pulsed Anabolic Metabolism and Acute Lipid Metabolism Activation: Supports physiological pulsed anabolic metabolism research, acute lipid metabolism activation studies, short-cycle tissue repair mechanism exploration research, and endocrine response baseline threshold verification research.

Natural Intermittent Hormone Release Pattern Mimicry: Supports long-acting DAC versions continuous and stable stimulation comparison research, body natural intermittent hormone release pattern mimicry studies, and more realistic physiological mechanism studies support research.

Short-Term Gradient Dosing Experiments and Acute Endocrine Phenotype Observation: Supports mild acute intervention, minimal experimental interference, and delayed metabolic burden related studies, suitable for short-term gradient dosing experiments, acute endocrine phenotype observation, and safety baseline verification, providing realistic reproducible physiological data for growth hormone pathway basic research.

Compared to long-acting DAC versions that produce continuous and stable stimulation, CND2 supports body natural intermittent hormone release pattern mimicry research, enabling more realistic physiological mechanism studies. Due to its mild acute intervention, minimal experimental interference, and delayed metabolic burden related studies, it is suitable for short-term gradient dosing experiments, acute endocrine phenotype observation, and safety baseline verification, providing realistic reproducible physiological data for growth hormone pathway basic research.

Core Product Advantages

Pure Non-DAC Physiological Structure: Pure CJC 1295 peptide, unmodified by chain DAC drug affinity complexes, supporting natural molecular metabolic characteristic retention research, abnormal albumin binding avoidance studies, and true endocrine pulse rhythm of the human body restoration research.

Precise Short Half-Life Pulsatile Effect: Supports natural rapid metabolization and clearance research, hormone accumulation and overstimulation prevention studies, long-acting peptides continuous additive effect related problem research, and daily physiological processes intermittent endocrine regulation simulation research.

2mg Low-Dose Safety Baseline Specification: Professional entry-level low-concentration design, suitable for short-cycle acute experiments, supporting model tolerance, endocrine desensitization, and physiological stress caused by high-dose long-acting interventions related avoidance studies, ensuring safe and controllable experimental process research.

High-Purity Low-Interference Physiological Regulation: Supports GHRH-GH-IGF-1 pathway highly selective targeting research, orderly physiological secretion triggering studies, cortisol and prolactin stress hormone interference related studies, and non-cumulative characteristics supporting clear and intuitive acute experimental procedure research.

Pharmaceutical-Grade Lyophilized Quality: Aseptic vacuum lyophilization process supports peptide complete activity stable retention research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). Aseptic integrated packaging of 10 vials, suitable for basic physiological research, university short-term endocrinology projects, and bulk wholesale purchases.

Specifications and Quality Control

Format: Lyophilized powder, 2mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).